STAGE II OVARIAN CANCER AJCC V8
Clinical trials for STAGE II OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests gentler hormone pill against harsh chemo for rare ovarian cancer
Disease control OngoingThis study aims to find out if a daily hormone pill (letrozole) works as well as or better than standard chemotherapy (paclitaxel/carboplatin) followed by the same pill for patients with advanced low-grade ovarian, fallopian tube, or peritoneal cancer. It involves 450 women who h…
Matched conditions: STAGE II OVARIAN CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Virtual support aims to calm cancer fears
Symptom relief TerminatedThis study aimed to test an online mental health program designed to help women with advanced breast or gynecologic cancers manage their fear of the cancer coming back or getting worse. Participants would have been randomly assigned to either the main program, which taught coping…
Matched conditions: STAGE II OVARIAN CANCER AJCC V8
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Can we predict who gets nerve damage from chemo?
Knowledge-focused OngoingThis study aims to create a tool to predict which cancer patients are most likely to develop nerve damage (like tingling or numbness in hands and feet) from a common class of chemotherapy drugs called taxanes. Researchers will follow over 1,300 patients with breast, lung, or ovar…
Matched conditions: STAGE II OVARIAN CANCER AJCC V8
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC